Mediran

Medicinal product

(Invented) name

Mediran

Active substance (s)

Ranitidinas

Strength

150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A02BA02, Ranitidine

Marketing authorisation holder

Sun Pharmaceutical Industries Europe B. V., Nyderlandai

Date of authorisation

1996-12-06

Date of renewal

2011-12-21

Documents

0164_3_Pakuotės lapelis_191017.docx

0164_3_Mediran_150mg_tab_RPP_191017.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Vienoje tabletėje yra	1 vnt.
Ranitidinas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
2635	8210	1008210	lizdinė plokštelė	N20		Nereceptinis	LT/1/96/0164/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-12	Išregistruotas
2011-12-21	Perregistruotas
1996-12-06	Registruotas